Kanamycin

Entity type image
Type: Keyphrase
Name: Kanamycin
First reported May 10 2013 - Updated May 10 2013 - 1 reports

Data on Biochemistry Discussed by Researchers at University of Michigan

(NewsRx) -- By a News Reporter-Staff News Editor at Tuberculosis Week -- Investigators publish new report on Biochemistry. According to news reporting originating from Ann Arbor, Michigan, by NewsRx correspondents, research stated, "The enhanced intracellular ... [Published NewsRX - May 10 2013]
First reported May 08 2013 - Updated May 08 2013 - 1 reports

Investigators from GenVec Zero in on Neuroepithelial Cells

By a News Reporter-Staff News Editor at Health & Medicine Week -- New research on Sensory Receptor Cells is the subject of a report. According to news originating from Gaithersburg, Maryland, by NewsRx correspondents, research stated, "To evaluate the ... [Published Equities.com - May 08 2013]
First reported Apr 27 2013 - Updated Apr 27 2013 - 1 reports

A monster called drug-resistant tuberculosis

Tuberculosis is a disease caused by the bacteria, Mycobacterium tuberculosis. According to the World Health Organisation (WHO), in 2011, 87 lakhs people fell ill with TB and 14 lakh died. India constitutes a major burden country with 20% of all TB cases ... [Published The Hindu - Apr 27 2013]

Quotes

..."Production of Polyclonal Antisera," in Immunochemical Protocols pages 1-5, Manson, ed., Humana Press 1992; Coligan et al., "Production of Polyclonal Antisera in Rabbits, Rats, Mice and Hamsters" in: Current Protocols in Immunology, section 2.4.1, 1992
...According to news reporting originating from Ann Arbor, Michigan, by NewsRx correspondents, research stated, "The enhanced intracellular survival (Eis) protein improves the survival of Mycobacterium smegmatis (Msm) in macrophages and functions as the acetyltransferase responsible for kanamycin A resistance, a hallmark of extensively drug-resistant (XDR) tuberculosis, in a large number of Mycobacterium tuberculosis (Mtb) clinical isolates. We recently demonstrated that Eis from Mtb (Eis_Mtb) efficiently multiacetylates a variety of... We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3."
...According to news originating from Gaithersburg, Maryland, by NewsRx correspondents, research stated, "To evaluate the ability of the Ad28.gfap.atoh1 to promote hair cell regeneration and hearing recovery in cochlea injured with kanamycin and furosemide. In vivo model of hair cell ablation and subsequent treatment with Atoh1."
...models by convection-enhanced delivery monitored with magnetic resonance imaging", Cancer ResearchResearch 1; 64(7):2572-9, 2004; Mamot et al., "Extensive distribution of liposomes in rodent brains and brain tumors following convection-enhanced delivery" , J Neurooncol 68(1):1-9, 2004]

More Content

All (27) | News (26) | Reports (0) | Blogs (1) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Therapeutic use of anti-CS1 antibodies [Published PharmCast - May 22 2013]
The U.S. must fight harder against tuberculosis [Published Bend Bulletin - May 20 2013]
Cuts in funding threaten to make TB even more d... [Published Albuquerque Journal - May 18 2013]
U.S. Must Fight Harder Against TB [Published Bloomberg - May 16 2013]
Use of a pneumococcal P4 peptide for enhancing ... [Published PharmCast - May 15 2013]
Antibacterial, antidiarrhoeal, and cytotoxic ac... [Published 7thSpace - May 12 2013]
Garlic and Ginger Inhibit Drug Resistant Bacteria [Published Health Impact News - May 10 2013]
Data on Biochemistry Discussed by Researchers a... [Published NewsRX - May 10 2013]
Investigators from GenVec Zero in on Neuroepith... [Published Equities.com - May 08 2013]
Recruitment, Assembly, and Molecular Architectu... [Published PLoS Biology - May 08 2013]
Peptides specific for human blood outgrowth end... [Published PharmCast - May 08 2013]
A monster called drug-resistant tuberculosis [Published The Hindu - Apr 27 2013]
Method of increasing cathepsin B-induced cleava... [Published PharmCast - Mar 21 2013]
Composition for improving efficiency of drug de... [Published PharmCast - Mar 19 2013]
Modified surface antigen [Published PharmCast - Mar 12 2013]
Solid drug tablets for implantable drug deliver... [Published PharmCast - Jan 15 2013]
Poor lab capacity expansion affects early detec... [Published PharmaBiz - Jan 15 2013]
Antibodies specific for DKK-1 and their uses [Published PharmCast - Jan 08 2013]
T2R taste receptors and genes encoding same [Published PharmCast - Jan 03 2013]
US FDA grants accelerated approval to Janssen' ... [Published PharmaBiz - Jan 03 2013]
Topical compositions and methods for epithelial... [Published PharmCast - Jan 02 2013]
District Court Rejects Argument that Hatch-Waxm... [Published Holman's Biotech IP Blog - Nov 29 2012]
Structurally designed shRNAs [Published PharmCast - Oct 12 2012]
Anti-virus therapy for respiratory diseases [Published PharmCast - Oct 10 2012]
MAPC generation of muscle [Published PharmCast - Sep 12 2012]
Health ministry finalizing rules to curb indisc... [Published PharmaBiz - Sep 03 2012]
Cell lines expressing T1R2/T1R3 hetero-oligomer... [Published PharmCast - Aug 03 2012]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
District Court Rejects Argument that Hatch-Waxm... [Published Holman's Biotech IP Blog - Nov 29 2012]
I noticed an interesting order issued on November 16 by the District Court hearing Monsanto v. E.I. DuPont De Nemours and Pioneer Hi-Bred International.  The case gathered quite a bit of attention last August when a jury awarded Monsanto a $1 billion ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.